December 12, 2024 04:28 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | INDIA bloc to knock on Supreme Court's doors over alleged EVM manipulation during Maharashtra polls | 'Babri Masjid should be rebuilt in Bengal's Murshidabad': TMC MLA Humayun Kabir sparks row | Rajnath Singh calls on Russian Prez Vladimir Putin in Moscow, discusses bilateral defence cooperation | Police to investigate conspiracy angle in Mumbai bus accident that killed 7 | Mamata Banerjee should lead INDIA bloc: Lalu Prasad Yadav | Opposition moves no-confidence motion against VP Jagdeep Dhankar in RS
Narendra Modi
Image: Narendra Modi Twitter page

PM Narendra Modi’s visit serves great inspiration to our team: Bharat Biotech

| @indiablooms | Nov 28, 2020, at 10:43 pm

Hyderabad/UNI: Bharat Biotech at Genome Valley in Shamirpet on the outskirts of the city, on Saturday said that they are humbled by the visit of Prime Minister Narendra Modi to the manufacturing facility.

Bharat Biotech, a leader in pandemic vaccines, also said we are truly honoured by this recognition.

Mr Modi's visit serves as a great inspiration to our team, and further reinforces our commitment towards scientific discovery, solving public health issues, and the nation’s fight against COVID-19, Bharat Biotech said in a release here.

COVAXIN™ India’s first indigenous vaccine with the Phase 3 clinical trial underway, is the first, largest, and the only efficacy trial in the developing world, involving a large number of volunteers across 25 sites.

The COVAXIN™ phase III trial is being conducted across India in 26,000 participants. The vaccine will be produced in the only-of-its-kind Biosafety Level 3 production facility in the world.

We take this opportunity to thank the Government of India, Regulators, our vaccine development partners, medical fraternity, medical investigators including hospitals for their relentless assistance and cooperation in the development of vaccines, also phase 3 clinical trials for COVAXIN, Hyderabad-based vaccine maker said.

'We greatly appreciate every volunteer who has come forward for the trial thus far and we thank you for your service to the nation.

Bharat Biotech reiterates our commitment towards developing a safe and efficacious vaccine for all', the release added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.